• 1
    Gitlin N. Subclinical portal-systemic encephalopathy. Am J Gastroenterol 1988; 83: 811.
  • 2
    Ross BD, Jacobson S, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994; 193: 457463.
  • 3
    Lockwood AH. Metabolic encephalopathies: opportunities and challenges. J Cereb Blood Flow Metab 1987; 7: 523526.
  • 4
    Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182: 1927.
  • 5
    McConnell JR, Antonson DL, Ong CS, Chu WK, Fox IJ, Heffron TG, Langnas AN, et al. Proton spectroscopy of brain glutamine in acute liver failure. HEPATOLOGY 1995; 22: 6974.
  • 6
    Geissler A, Ernst T, Ross BD, Kreis R, Moats R, Shonk T, Villamil F. Reversal of hepatic encephalopathy after liver transplantation: a proton MRS study [Abstract]. Hepatogastroenterology 1993; 40: 37.
  • 7
    Villamil F, Ernst T, Ross BD, Kreis R, Geissler A, Moats R, Shonk T, et al. Reversal of hepatic encephalopathy after liver transplantation–a proton MRS study [Abstract]. Gastroenterology 1993; 104: 1015A.
  • 8
    Barron TF, Devenyi AG, Mamourian AC. Symptomatic manganese neurotoxicity in a patient with chronic liver disease: correlation of clinical symptoms with MRI findings. Pediatr Neurol 1994; 10: 145148.
  • 9
    Inoue E, Hori S, Narumi Y, Fujita M, Kuriyama K, Kadota T, Kuroda C. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991; 179: 551555.
  • 10
    Kulisevsky J, Pujol J, Balanzo J, Junque C, Deus J, Capdevilla A, Villanueva C. Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. HEPATOLOGY 1992; 16: 13821388.
  • 11
    Uchino A, Aoki T, Ohno M. Portal-systemic encephalopathy: report of a case with unusual MR findings. Radiat Med 1993; 11: 2123.
  • 12
    Norton NS, McConnell JR, Zetterman RK, Rodriguez Sierra JF. A quantitative evaluation of magnetic resonance image signal changes of the brain in chronic hepatic encephalopathy. J Hepatol 1994; 21: 764770.
  • 13
    Uchino A, Hasuo K, Matsumoto S, Masuda K. Cerebral magnetic resonance imaging of liver cirrhosis patients. Clin Imaging 1994; 18: 123130.
  • 14
    Taylor Robinson SD, Oatridge A, Hajnal JV, Burroughs AK, McIntyre N, deSouza NM. MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 1995; 10: 175188.
  • 15
    Thuluvath PJ, Edwin D, Yue NC, deVilliers C, Hochman S, Klein A. Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy. HEPATOLOGY 1995; 21: 440442.
  • 16
    Pomier Layrargues G, Spahr L, Butterworth RF. Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 1995; 345: 735.
  • 17
    Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346: 270274.
  • 18
    Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL, et al. A comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 1977; 72: 573578.
  • 19
    Schomerus H, Schreiegg J. Prevalence of latent portal systemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Z Gastroenterol 1993; 31: 231234.
  • 20
    Gyr K, Meier R, Haüssler J, Bouletreau P, Fleig WE, Gatta A, Holstege A, et al. Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double-blind, randomised, placebo-controlled multicentre study. Gut 1996; 39: 319324.
  • 21
    Walba D, Thomas L, Elektrolythaushalt. In: ThomasL, ed. Labor und Diagnose. Vol 1, Ed 4. Marburg: Medizinische Verlagsgesellschaft, 1992: 310.
  • 22
    Geissler A, Fründ R, Kohler S, Eichhorn HM, Krämer BK, Feuerbach S. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy. Radiology 1995; 194: 693697.
  • 23
    Horikoshi T, Yagi S, Fukamachi A. Incidental high-intensity foci in white matter on T2-weighted magnetic resonance imaging. Frequency and clinical significance in symptom-free adults. Neuroradiology 1993; 35: 151155.
  • 24
    Kreis R, Farrow NA, Ross BD. Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 1990; 336: 635636.
  • 25
    Gupta RK, Saraswat VA, Poptani H, Dhiman RK, Kohli A, Gujral RB, Naik SR. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure. Am J Gastroenterol 1993; 88: 670674.
  • 26
    Lien YH, Shapiro JI, Chan L. Effects of hypernatremia on organic brain osmoles. J Clin Invest 1990; 85: 14271435.
  • 27
    Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 1991; 88: 303309.
  • 28
    Norenberg MD, Baker L, Norenberg LO, Blicharska J, Bruce Gregorios JH, Neary JT. Ammonia-induced astrocyte swelling in primary culture. Neurochem Res 1991; 16: 833836.
  • 29
    Videen JS, Michaelis T, Pinto P, Ross BD. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J Clin Invest 1995; 95: 788793.
  • 30
    Häussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994; 107: 14751480.
  • 31
    Lien YH. Role of organic osmolytes in myelinolysis. A topographic study in rats after rapid correction of hyponatremia. J Clin Invest 1995; 95: 15791586.
  • 32
    Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993; 187: 433437.
  • 33
    Chang L, Miller BL, McBride D, Cornford M, Oropilla G, Buchthal S, Chiang F, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995; 197: 525531.
  • 34
    Gregorios JB, Mozes LW, Norenberg MD. Morphologic effects of ammonia on primary astrocyte cultures. II. Electron microscopic studies. J Neuropathol Exp Neurol 1985; 44: 404414.
  • 35
    Norenberg MD. The role of astrocytes in hepatic encephalopathy. Neurochem Pathol 1987; 6: 1333.
  • 36
    Galea E, Estrada C. Quabain-sensitive choline transport system in capillaries isolated from bovine brain. J Neurochem 1992; 59: 936941.
  • 37
    Klein J, Gonzalez R, Koppen A, Loffelholz K. Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain. Neurochem Int 1993; 22: 293300.
  • 38
    Rao VL, Therrien G, Butterworth RF. Choline acetyltransferase and acetylcholinesterase activities are unchanged in brain in human and experimental portal-systemic encephalopathy. Metab Brain Dis 1994; 9: 401407.
  • 39
    Richards TL. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. AJR 1991; 5: 10731078.
  • 40
    McBride DQ, Miller BL, Nikas DL, Buchthal S, Chang L, Chiang F, Booth RA. Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 1995; 2: 137144.
  • 41
    Roser W, Hagberg G, Mader I, Brunnschweiler H, Radue EW, Seelig J, Kappos L. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 1995; 6: 811817.
  • 42
    Taylor Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994; 9: 347359.
  • 43
    Burt CT, Cheng HM, Jungalwalla F. 31P NMR studies of excised gray and white calf brain. Comp Biochem Physiol B 1989; 94: 679685.
  • 44
    Swain M, Butterworth RF, Blei AT. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. HEPATOLOGY 1992; 15: 449453.
  • 45
    Bosman DK, Deutz NE, De Graaf AA, v.d. Hulst RW, Van Eijk HM, Bovee WM, Maas MA, et al. Changes in brain metabolism during hyperammonemia and acute liver failure: results of a comparative 1H-NMR spectroscopy and biochemical investigation. HEPATOLOGY 1990; 12: 281290.
  • 46
    Pujol A, Pujol J, Graus F, Rimola A, Peri J, Mercader JM, Garcia Pagan JC, et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993; 43: 6569.
  • 47
    Kulisevsky J, Pujol J, Deus J, Junque C, Balanzo J, Avila A, Capdevila A. Persistence of MRI hyperintensity of the globus pallidus in cirrhotic patients: a 2-year follow-up study. Neurology 1995; 45: 995997.
  • 48
    Tarter RE, Switala JA, Arria A, Plail J, Van Thiel DH. Subclinical hepatic encephalopathy. Comparison before and after orthotopic liver transplantation. Transplantation 1990; 50: 632637.
  • 49
    O'Carroll RE, Hayes PC, Ebmeier KP, Dougall N, Murray C, Best JJ, Bouchier IA, et al. Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 1991; 337: 12501253.
  • 50
    Jessy J, Mans AM, DeJoseph MR, Hawkins RA. Hyperammonaemia causes any of the changes found after portacaval shunting. Biochem J 1990; 272: 311317.
  • 51
    Devenyi AG. Barron TF, Mamourian AC. Dystonia hyperintense basal ganglia, and high whole blood manganese levels in Alagille's syndrome. Gastroenterology 1994; 106: 10681071.
  • 52
    Tien R, Arieff AI, Kucharczyk W, Wasik A, Kucharczyk J. Hyponatremic encephalopathy: is central pontine myelinolysis a component? Am J Med 1992; 92: 513522.
  • 53
    Harper C, Kril J. Brain atrophy in chronic alcoholic patients: a quantitative pathological study. J Neurol Neurosurg Psychiatry 1985; 48: 211217.
  • 54
    Zeneroli ML, Cioni G, Crisi G, Vezzelli C, Ventura E. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study. Magn Reson Imaging 1991; 9: 295302.